Uzbekistan’s Competition Committee is investigating claims that pharmaceutical importers and wholesale distributors are forcing pharmacies to buy unwanted medicines alongside high-demand drugs, a practice that may breach competition law and expose offenders to fines of up to five percent of relevant revenues.
